STAT3 and rheumatoid arthritis: MiR-671-5p restricted the proliferation of RA-FLSs, while STAT3 declined the effects of miRNAs, those data suggesting the potential therapeutic approach of using miRNAs on the FLS and thus, prevent disease progression [122].